STERIS’ (TSE:STE – Free Report) – Equities research analysts at Cormark decreased their FY2024 earnings per share estimates for shares of STERIS’ in a note issued to investors on Tuesday, November 5th. Cormark analyst B. Watson now expects that the company will post earnings of $0.77 per share for the year, down from their previous estimate of $0.90.
STERIS’ (TSE:STE – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of C$0.12 by C$0.02. The firm had revenue of C$231.38 million during the quarter, compared to analysts’ expectations of C$226.20 million.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Articles
- Five stocks we like better than STERIS’
- What is the Australian Securities Exchange (ASX)
- What a Trump Win Looks Like for the Market Now and Into 2025
- Options Trading – Understanding Strike Price
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
